Muscle Research Unit, Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité, Universitätsmedizin Berlin, Berlin, Germany.
Charité Universitätsmedizin, Berlin, Germany.
Animal Model Exp Med. 2022 Oct;5(5):453-460. doi: 10.1002/ame2.12280. Epub 2022 Oct 8.
The aim of the study was to demonstrate the efficacy of human muscle stem cells (MuSCs) isolated using innovative technology in restoring internal urinary sphincter function in a preclinical animal model.
Colonies of pure human MuSCs were obtained from muscle biopsy specimens. Athymic rats were subjected to internal urethral sphincter damage by electrocauterization. Five days after injury, 2 × 10 muscle stem cells or medium as control were injected into the area of sphincter damage (n = 5 in each group). Peak bladder pressure and rise in pressure were chosen as outcome measures. To repeatedly obtain the necessary pressure values, telemetry sensors had been implanted into the rat bladders 10 days prior to injury.
There was a highly significant improvement in the ability to build up peak pressure as well as a pressure rise in animals that had received muscle stem cells as compared to control (p = 0.007) 3 weeks after the cells had been injected. Only minimal histologic evidence of scarring was observed in treated rats.
Primary human muscle stem cells obtained using innovative technology functionally restore internal urethral sphincter function after injury. Translation into use in clinical settings is foreseeable.
本研究旨在展示使用创新技术分离的人肌肉干细胞(MuSCs)在临床前动物模型中恢复内部尿道括约肌功能的疗效。
从肌肉活检标本中获得纯人 MuSCs 集落。通过电灼使去势大鼠的内部尿道括约肌受损。在损伤后 5 天,将 2×10 个肌肉干细胞或对照培养基注入括约肌损伤区域(每组 n=5)。选择膀胱压峰值和压力升高作为结果指标。为了反复获得必要的压力值,在损伤前 10 天将遥测传感器植入大鼠膀胱。
与对照组相比,接受肌肉干细胞治疗的动物在建立峰值压力和压力上升方面的能力有了显著提高(p=0.007),这是在细胞注射 3 周后观察到的。在治疗大鼠中仅观察到轻微的瘢痕组织学证据。
使用创新技术获得的原代人肌肉干细胞在损伤后可恢复内部尿道括约肌功能。预计可将其转化用于临床应用。